|
1
|
Greenlee RT, Hill-Harmon MB, Murray T and
Thun M: Cancer statistics, 2001. CA Cancer J Clin. 51:15–36. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Presnell SC, Petersen B and Heidaran M:
Stem cells in adult tissues. Semin Cell Dev Biol. 13:369–376. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Reya T, Morrison SJ, Clarke MF and
Weissman LL: Stem cells, cancer, and cancer stem cells. Nature.
414:105–111. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bonnet D and Dick JE: Human acutemyeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dontu G, Abdalla WM, Fole JM, et al: In
vitro propagation and transcriptional profiling of human mammary
stem/progenitor cells. Genes Dev. 17:1253–1270. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bapat SA, Mali AM, Koppikar CB and Kurrey
NK: Stem and progenitor-like cells contribute to the aggressive
behavior of human epithelial ovarian cancer. Cancer Res.
65:3025–3029. 2005.PubMed/NCBI
|
|
8
|
Singh SK, Hawkins C, Clarke ID, et al:
Identification of human brain tumor initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Horst D, Kriegl L, Engel J, Kirchner T and
Jung A: CD133 expression is an independent prognostic marker for
low survival in colorectal cancer. Brit J Cancer. 99:1285–1289.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shapiro HM: Microbial analysis at the
single-cell level: Tasks and techniques. J Microbiol Methods.
42:3–16. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kruger J, Singh K, O'Neill A, Jackson C,
Morrison A and O'Brien P: Development of a microfluidic device for
fluorescence activated cell sorting. J Micromech Microeng.
12:486–494. 2002. View Article : Google Scholar
|
|
12
|
Preffer FI, Dombkowski D, Sykes M, Scadden
D and Yang YG: Lineage-negative side-population (SP) cells with
restricted hematopoietic capacity circulate in normal human adult
blood: Immunophenotypic and functional characterization. Stem
Cells. 20:417–427. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dean M, Fojo T and Bates S: Tumor stem
cells and drug resistance. Nat Rev Cancer. 5:275–284. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Todaro M, Zerilli M, Ricci-Vitiani L, et
al: Autocrine production of interleukin-4 and interleukin-10 is
required for survival and growth of thyroid cancer cells. Cancer
Res. 66:1491–1499. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Conticello C, Pedini F, Zeuner A, et al:
IL-4 protects tumor cells from anti-CD95 and chemotherapeutic
agents via up-regulation of antiapoptotic proteins. J Immunol.
172:5467–5477. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Qz H, Xz L, Wang K, et al: Isolation and
characterization of cancer stem cells from high grade serous
ovarian carcinomas. Cell Physiol Biochem. 33:173–184. 2014.
View Article : Google Scholar
|
|
17
|
Yoo MH and Hatfield DL: The cancer stem
cell theory: Is it correct? Mol Cells. 26:514–516. 2008.PubMed/NCBI
|
|
18
|
Hirschmann-Jax C, Foster AE, Wulf GG, et
al: A distinct 'side population' of cells with high drug efflux
capacity in human tumor cells. Proc Natl Acad USA. 101:14228–14233.
2004. View Article : Google Scholar
|
|
19
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
et al: Identification and expansion of human
colon-cancer-initiating cells. Nature. 445:111–115. 2007.
View Article : Google Scholar
|
|
20
|
Eramo A, Ricci-Vitiani L, Zeuner A, et al:
Chemotherapy resistance of glioblastoma stem cells. Cell Death
Differ. 13:1238–1241. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dancescu M, Rubio-Trujillo M, Biron G,
Bron D, Delespesse G and Sarfati M: Interleukin 4 protects chronic
lymphocytic leukemic B cells from death by apoptosis and
upregulates Bcl-2 expression. J Exp Med. 176:1319–1326. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kieslinger M, Woldman I, Moriggl R, et al:
Antiapoptotic activity of Stat5 required during terminal stages of
myeloid differentiation. Genes Dev. 14:232–244. 2000.PubMed/NCBI
|
|
23
|
Prokopchuk O, Liu Y, Henne-Bruns D and
Kornmann M: Interleukin-4 enhances proliferation of human
pancreatic cancer cells: Evidence for autocrine and paracrine
actions. Br J Cancer. 92:921–928. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Todaro M, Perez AM, Di BA, et al: Colon
Cancer Stem Cells Dictate Tumor Growth and Resist Cell Death by
Production of Interleukin-4. Cell Stem Cell. 1:389–402. 2007.
View Article : Google Scholar
|
